Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 5377 of 6351
-
Eczema study sheds light on skin disease and treatment options
Knowledge-focused Stopped earlyAtopic dermatitis (eczema) is a complicated skin condition. In fact, it represents many different underlying problems. These include abnormalities in the skin barrier, the immune system and the ability to handle different bacteria. Despite many recent gains in the understanding o…
Sponsor: Women's College Hospital • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
Mold toxin in food may fuel gut disease, scientists investigate
Knowledge-focused Recruiting nowInflammatory bowel disease (IBD) are lifelong chronic diseases affecting the gastrointestinal tract. The precise etiology and the different actors participating to the pathophysiological process leading to the disease development are still not well understood. A complex interacti…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Spine surgery pain relief without opioids?
Symptom relief CompletedThe purpose of this clinical trial is to evaluate whether bilateral lumbar erector spinae plane (ESP) block can reduce postoperative pain in adult patients undergoing lumbar spine surgery. The study also assesses the safety of this method and its effects on the recovery process. …
Sponsor: Kutahya City Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Can a common ADHD drug boost depression treatment?
Symptom relief By invitation onlyThis study analyzes the affects or Adderall extended-release (XR) in Subjects receiving brain stimulation therapy for the treatment of Major Depressive Disorder. Subjects will be assigned by chance to active or placebo group. Active group will be asked to take one 15 mg pill once…
Early phase 1 • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
Are cirrhosis patients getting the shots they need? french study finds out
Knowledge-focused Completedthe purpose of this study is to estimate vacinal coverage against hepatitis A and B viruses, pneumococcus, diphtheria/tetanos and poliomyelitis, influenza virus and covid in cirrhotic patients followed in general hospitals of France and to show the
Sponsor: Centre Hospitalier Sud Francilien • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
New shakes aim to fight malnutrition in adults
Disease control OngoingThe aim of this study is to evaluate compliance, acceptability, gastrointestinal tolerance, nutrient intake, appetite, nutritional status, and safety of four new ready to drink ONS. This is a prospective, longitudinal, 28-day intervention study with a 1-day baseline period. Durin…
Sponsor: Nutricia UK Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Gentler gas pressure may ease Kids' pain after appendix surgery
Symptom relief CompletedThe purpose of this study is to asses whether the pressure used for the pneumoperitoneum during laparoscopic surgery in children affects their postoperative pain levels.
Sponsor: University Children's Hospital, Zurich • Aim: Symptom relief
Last updated Aug 01, 2026 00:00 UTC
-
New cancer pill AN4005 enters first human tests
Disease control Recruiting nowOpen-label, multicenter, phase 1 study to investigate the safety, tolerability, and PK of AN4005 in patients with advanced tumors. This study is a first-in-human, dose escalation study with the objective to establish the MTD and/or RP2D of AN4005. Except for Dose Level 0 (50 mg)…
Phase 1 • Sponsor: Adlai Nortye Biopharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Can a simple referral program reduce COVID-19 health gaps?
Knowledge-focused CompletedThe goal of this real world efficacy study is to understand the benefit of universal social needs screening, community-based service referrals, and telephonic follow-up as a scalable strategy for preventing COVID-19 transmission, and for addressing the secondary health effects of…
Sponsor: Andrea Wallace • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
New drug cocktail aims to reset gulf war illness symptoms
Symptom relief CompletedGulf War Illness is a condition that affects multiple major organ systems, resulting in a diverse array of symptoms that include debilitating fatigue, memory and cognition difficulties, headaches, sleep disturbances, gastrointestinal problems, skin rashes, and musculoskeletal/joi…
Phase 1 • Sponsor: Nova Southeastern University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
MS drug safety in pregnancy under scrutiny: new study tracks birth outcomes
Knowledge-focused OngoingIn this study, researchers will learn more about the effects of diroximel fumarate (DRF), also known as VUMERITY®, when taken during pregnancy in people with multiple sclerosis, also known as MS. In MS, the immune system attacks the nerves in the brain and spinal cord. The affect…
Sponsor: Biogen • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Glowing dye could help surgeons see blood flow during reconstruction
Diagnosis OngoingThe objective of this study is to assess whether Near-Infrared Fluorescence/NIR Imaging perfusion alters intraoperative management of the flap or of the participant wound bed.
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 07:56 UTC
-
New decision tool aims to reduce aggressive End-of-Life cancer care
Knowledge-focused OngoingSequential comparative prospective interventional study evaluating the impact of the use of an optimization device of the decision of cancer treatment on aggressiveness of end of life care. Comparison between a first period, period (A), of care as usual and a second period, perio…
Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
New hope for faster surgery recovery: drug may cut Wake-Up time
Symptom relief CompletedPostoperative recovery is an important part of the patient's experience. A good recovery period is an important guarantee for the recovery of postoperative organs and functions after surgery. However, the delay in awakening after general anesthesia remains one of the biggest chal…
Phase 4 • Sponsor: RenJi Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Remote alcohol withdrawal treatment shows promise in small pilot study
Symptom relief CompletedThis study will evaluate the feasibility of delivering symptom-triggered alcohol withdrawal management by telemedicine and determine whether this intervention is satisfactory to patients.
Sponsor: Centre for Addiction and Mental Health • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
New registry checks migraine drug safety in pregnancy
Knowledge-focused Recruiting nowThe purpose of the study is to evaluate fetal, maternal, and infant outcomes through 12 months of age.
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
10,000 knee pain patients enrolled in massive treatment registry
Knowledge-focused Recruiting nowThe registry will capture prospective data on patients receiving pain management for chronic pain due to knee osteoarthritis (OA) or pain optimization for knee arthroplasty due to knee OA. The OA pain therapies may include cryo nerve block, radiofrequency ablation (RFA), intra-ar…
Sponsor: Pacira Pharmaceuticals, Inc • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Hands-On therapy may speed up concussion healing
Symptom relief Stopped earlyThis project aims to study whether adding osteopathic manipulative treatment (OMT) to usual care of concussed patients will enhance their recovery.
Sponsor: Michigan State University • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Gut bacteria may hold key to why arthritis drugs stop working in kids
Knowledge-focused Recruiting nowIdiopathic juvenile arthritis includes 20% of patients with arthritis with enthesitis or juvenile spondyloarthropathy. This is treated with anti-inflammatory drugs and then followed by biotherapy with DMARDs (Drugs Modifying the Activity of Rheumatic Disease) if the former are in…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Melanoma drug combo trial halted after just 3 patients
Disease control Stopped earlyThis phase II trial studies how well encorafenib and binimetinib work before surgery in treating patients with BRAF V600-mutated stage IIIB-D melanoma that has spread to the lymph nodes. Encorafenib and binimetinib may stop the growth of tumor cells by blocking some of the enzyme…
Phase 2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC